Company: BIAF
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001641172-25-024172
Chunk: 5

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 3.02
Chunk 5
---
Item
3.02 Unregistered Sales of Equity Securities.

The
information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. The Series B Preferred Stock, Warrants,
and New Warrants are being issued without registration under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2)
of the Securities Act as a transaction not involving a public offering and Rule 506 promulgated under the Securities Act as sales to
accredited investors, and in reliance on similar exemptions under applicable state laws.

Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.